KRT5 and breast cancer: NT2.5-LM lung metastases are ERBB2-positive (Fig. 1e), express similarly low levels of AE1/3 and EGFR, and are similarly negative for CK5 and CK6, when compared to NT2.5 mammary tumors (Fig. S3).